YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services

Not Applicable

Recruiting

Conditions: Opioid-use Disorder
HIV Prevention Program

Interventions: Behavioral: Contingency Management with stepped care to PrEP adherence and support services (CoMPASS)

First Posted Date: 2021-02-04

Last Posted Date: 2025-03-13

Lead Sponsor: Yale University

Target Recruit Count: 526

Registration Number: NCT04738825

Locations: 🇺🇸
Recovery Network of Programs, Inc, Bridgeport, Connecticut, United States
🇺🇸
Liberations Program, Inc, Bridgeport, Connecticut, United States
🇺🇸
Stanley Street Treatment and Resource Center, Fall River, Massachusetts, United States

and more 3 locations

Being Present With Art: The Impact of Mindful Engagement With Art on Awareness and Connection

Not Applicable

Completed

Conditions: Stress

Interventions: Behavioral: Art Pedagogy and Mindfulness

First Posted Date: 2021-01-25

Last Posted Date: 2021-01-25

Lead Sponsor: Yale University

Target Recruit Count: 45

Registration Number: NCT04722367

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study

Recruiting

Conditions: Cocaine Use Disorder
Healthy Controls

Interventions: Radiation: 11C-UCB-J

First Posted Date: 2021-01-22

Last Posted Date: 2024-11-07

Lead Sponsor: Yale University

Target Recruit Count: 80

Registration Number: NCT04721418

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Developing Online Interventions to Reduce Stigma-Related Stress, Sexual Health, and HIV Risk Among Young Chinese MSM

Not Applicable

Completed

Conditions: LGBTQ
HIV Risk
Sexual Behavior

Interventions: Behavioral: Self-monitoring control
Behavioral: ESTEEM iCBT

First Posted Date: 2021-01-22

Last Posted Date: 2024-02-16

Lead Sponsor: Yale University

Target Recruit Count: 120

Registration Number: NCT04718194

Locations: 🇨🇳
Central South University, Hunan, China

Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans

Phase 1

Active, not recruiting

Conditions: Major Depressive Disorder
Depression

Interventions: Drug: 0.1 mg/kg Dimethyltryptamine (DMT)
Drug: 0.3 mg/kg Dimethyltryptamine (DMT)

First Posted Date: 2021-01-15

Last Posted Date: 2024-12-12

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT04711915

Locations: 🇺🇸
Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine, West Haven, Connecticut, United States

SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs

Active, not recruiting

Conditions: Peripheral Arterial Disease

First Posted Date: 2021-01-14

Last Posted Date: 2025-01-13

Lead Sponsor: Yale University

Target Recruit Count: 458

Registration Number: NCT04710563

Locations: 🇺🇸
Yale New Haven Health, New Haven, Connecticut, United States

Photodegraded Edible Food Dyes

Not Applicable

Withdrawn

Conditions: Thyroid; Functional Disturbance

Interventions: Dietary Supplement: Erythrosine, prepared in drinking water (0.69 mg/kg bw/day)
Dietary Supplement: SODIS-treated erythrosine, prepared in drinking water (0.69 mg/kg bw/day)
Dietary Supplement: Iodine, prepared in drinking water 0.075 mg/kg bw/day)

First Posted Date: 2021-01-14

Last Posted Date: 2022-11-01

Lead Sponsor: Yale University

Registration Number: NCT04708704

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II

Phase 1

Recruiting

Conditions: Cannabis

Interventions: Drug: Inhaled THC
Drug: Placebo

First Posted Date: 2021-01-11

Last Posted Date: 2025-03-06

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT04704271

Locations: 🇺🇸
Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine, West Haven, Connecticut, United States
🇺🇸
Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine, West Haven, Connecticut, United States

Parental Guidance for Failure to Launch.

Not Applicable

Completed

Conditions: Anxiety Disorders
Failure to Launch
Hikikomori

Interventions: Behavioral: SPACE parental-guidance

First Posted Date: 2021-01-11

Last Posted Date: 2024-01-22

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT04704583

Locations: 🇺🇸
Yale University Child Study Center, New Haven, Connecticut, United States

The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer

Phase 2

Active, not recruiting

Conditions: Advanced Non-small Cell Lung Cancer

Interventions: Drug: NC318 400 mg
Drug: NC318 800 mg
Drug: Pembrolizumab

First Posted Date: 2021-01-07

Last Posted Date: 2025-05-13

Lead Sponsor: Yale University

Target Recruit Count: 159

Registration Number: NCT04699123

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy